| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 233.20B | 185.97B | 177.19B | 169.52B | 163.02B | 159.42B |
| Gross Profit | 80.26B | 62.55B | 60.12B | 57.69B | 57.94B | 57.16B |
| EBITDA | 16.48B | 13.76B | 13.36B | 12.38B | 13.75B | 13.57B |
| Net Income | 9.71B | 8.20B | 8.20B | 7.64B | 8.50B | 8.28B |
Balance Sheet | ||||||
| Total Assets | 159.12B | 149.82B | 141.34B | 129.90B | 122.86B | 117.91B |
| Cash, Cash Equivalents and Short-Term Investments | 72.23B | 67.83B | 63.06B | 59.22B | 60.92B | 57.32B |
| Total Debt | 1.63B | 1.15B | 563.00M | 1.09B | 830.00M | 1.07B |
| Total Liabilities | 62.96B | 58.55B | 56.35B | 52.80B | 50.56B | 50.27B |
| Stockholders Equity | 96.16B | 91.27B | 84.98B | 77.10B | 72.30B | 67.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.78B | 8.24B | 918.00M | 7.00B | 16.23B |
| Operating Cash Flow | 0.00 | 9.13B | 11.54B | 3.47B | 8.75B | 18.07B |
| Investing Cash Flow | 0.00 | -1.83B | -4.50B | -2.41B | -1.35B | -1.55B |
| Financing Cash Flow | 0.00 | -2.44B | -2.18B | -2.97B | -4.28B | -2.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥129.47B | 10.89 | ― | 2.23% | 9.57% | 33.85% | |
71 Outperform | ¥88.47B | 5.42 | 6.96% | 2.98% | 1.15% | 86.72% | |
65 Neutral | ¥189.29B | 27.65 | ― | 0.64% | 57.01% | 91.03% | |
64 Neutral | ¥78.15B | 10.29 | ― | 2.11% | 6.04% | 93.19% | |
63 Neutral | ¥128.62B | 16.01 | ― | 1.54% | 4.78% | 3.50% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥44.92B | 15.79 | ― | 3.31% | 0.88% | -138.66% |